Amlitelimab
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for Amlitelimab, covering 2025-09-19 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates [Phase 1]